Article Search
닫기

Journal of Cancer Prevention

Review

J Cancer Prev 2023; 28(4): 150-159

Published online December 30, 2023

https://doi.org/10.15430/JCP.2023.28.4.150

© Korean Society of Cancer Prevention

Cadmium-induced Carcinogenesis in Respiratory Organs and the Prostate: Insights from Three Perspectives on Toxicogenomic Approach

Jun Lee1 , Dong Yeop Shin1 , Yujin Jang1 , Jun Pyo Han1 , Eun-Min Cho2,* , Young Rok Seo1,*

1Department of Life Science, Institute of Environmental Medicine for Green Chemistry, Dongguk University Biomedi Campus, Goyang, 2Department of Nano, Chemical & Biological Engineering, College of Natural Science and Engineering, Seokyeong University, Seoul, Korea

Correspondence to :
Eun-Min Cho, E-mail: eunmin@skuniv.ac.kr, https://orcid.org/0000-0002-6906-9618
Young Rok Seo, E-mail: seoyr@dongguk.edu, ORCID: https://orcid.org/0000-0002-4093-4073
*These authors contributed equally to this work (paper) as co-correspondence authors.

Received: December 15, 2023; Accepted: December 25, 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cadmium (Cd) exposure primarily occurs through inhalation, either by smoking or occupational exposure to contaminated air. Upon inhalation, Cd ultimately reaches the prostate through the bloodstream. In this review, we investigate the carcinogenic potential of Cd in both respiratory organs and the prostate. Specifically, this review examines cellular metabolism, comprehensive toxicity, and carcinogenic mechanisms by exploring gene ontology, biological networks, and adverse outcome pathways. In the respiratory organs, Cd induces lung cancer by altering the expression of IL1B and FGF2, causing DNA damage, reducing cell junction integrity, and promoting apoptosis. In the prostate, Cd induces prostate cancer by modifying the expression of EDN1 and HMOX1, leading to abnormal protein activities and maturation, suppressing tumor suppressors, and inducing apoptosis. Collectively, this review provides a comprehensive understanding of the carcinogenic mechanisms of Cd in two different organs by adopting toxicogenomic approaches. These insights can serve as a foundation for further research on cadmium-induced cancer, contributing to the establishment of future cancer prevention strategies.

Keywords: Cadmium, Carcinogenesis, Computational biology, Toxicogenetics, Adverse outcome pathways

Cadmium (Cd) is a naturally occurring heavy metal that is artificially emitted into the atmosphere through human activities such as smoking and industrial processes. Humans are primarily exposed to Cd through inhalation, ingestion, and skin contact [1]. In scenarios of dietary intake, only about 5% of the ingested amount is absorbed through the gastrointestinal tract [2]. Cd exposure via skin contact is rare, with this exposure route accounting for only approximately 0.5% of Cd absorption [3]. However, Cd uptake through inhalation is quite high, with up to 90% of the inhaled dose being deposited in the lungs [4].

The inhalation of Cd scenario which is the most significant route of absorption in the human body can be divided into two cases. For the general case, smoking is the primary route of Cd exposure [5]. For occupational case, Cd fume emitted from industrial activities such as the production of nickel-Cd batteries, metal coatings, and pigments [6,7] is a kind of causes [8]. Cd exposure through smoking or polluted air can have serious adverse effects including lung cancer. Cd can induce lung cancer, which has already been widely recognized through numerous research studies. Numerous reports have found that cadmium inhalation leads to respiratory cancers including tracheal cancer, bronchus cancer and lung cancer [9-11]. Additionally, occupational exposure to Cd is known to have adverse effects on the prostate [12,13]. Cd absorbed through the respiratory system can circulate through the bloodstream and reach the prostate (Fig. 1) [14-16]. The mechanisms underlying the onset of prostate cancer due to Cd are not fully understood, so the need for further research is increasing.

Figure 1. The route through which inhaled cadmium passes the respiratory organs and circulates in the bloodstream to reach the prostate.

Public databases such as the Gene Expression Omnibus (GEO) provide recently detailed biological data, including experimental design, methodology, and sample attributes for high-throughput gene expression studies [17]. Here, we reviewed studies on Cd exposure in human respiratory organs and the prostate from the GEO database and compiled a list of differentially expressed genes (DEGs) associated with Cd exposure in each organ.

This review used three different toxicogenomic approaches including gene ontology (GO), biological network, and adverse outcome pathways (AOPs). The GO serves as an inclusive platform for categorizing genes according to their biological process (BP), cellular component (CC), molecular function (MF) [18], thereby offering comprehensive insights into the biological functions affected by differential gene expression at the cellular and molecular levels. Given the abundance of biological data in databases [19], the ability of researchers to effectively find the desired information has become crucial. Biological network is an effective approach for gaining an extensive understanding of heavy metal-induced carcinogenesis, diseases, and identification of central genes. Moreover, the direct relations between central genes, cell processes, and diseases enhances the ability to predict protein markers specific to carcinogenesis. AOP provides a comprehensive overview of the mechanisms underlying the carcinogenic effects of Cd. AOP is a biological mechanism consisting of a series of cellular and molecular events required to demonstrate adverse outcomes (AOs) when an organism is exposed to a noxious substance such as Cd [20].

This review reports our current understanding of the toxic mechanisms underlying the toxicity of Cd. Especially, its carcinogenic effects on the respiratory organs and prostate by exploring using toxicogenomic approaches. We provide biological understanding of respiratory organs and prostate cancer induced by cadmium. This understanding can contribute to the prevention and treatment of these cancers.

Respiratory toxicity of Cd from the perspective of GO

To gain insights into the toxicity of Cd inhalation in respiratory organs, we examined gene expression data (GSE128263) from human bronchial epithelial cells (BEAS-2B) exposed to Cd. The top 10 BPs, CCs, and MFs from the Cd exposure study (adjusted P-value < 0.05) were identified respectively (Table 1). For the activated ontologies within the BPs, most gene ontologies were related to Cd metabolism and protective effects such as 'detoxification of inorganic compound,’ ‘stress response to metal ion,’ and ‘response to Cd ion.’ Among the suppressed ontologies, ‘negative regulation of pathway-restricted suppressor of mothers against decapentaplegic (SMAD) protein phosphorylation’ likely plays a protective role against carcinogens. The SMAD protein is phosphorylated by TGF-β, activin, or bone morphogenetic proteins, thereby regulating target gene expression [21,22]. Souchelnytskyi et al. [23] demonstrated down-regulation of the SMAD protein phosphorylation as indication of abnormal transcription of its target genes. SMAD proteins are components of the TGF-β family signaling pathways [24], and dysfunction of TGF-β family signaling pathways causes bronchopulmonary diseases [25]. The suppression of ‘negative regulation of cellular response to growth factor stimulus’ can be interpreted as a healing effect. Because growth factors play a key role in tissue interactions, normal lung development, homeostasis [26], tissue repair and tissue regeneration [27]. When considering the integrated activation and suppression of BPs, there was a clear increase in Cd metabolism, whereas defense against carcinogens, bronchial homeostasis, recovery, and regeneration in bronchial tissue decreased.

Gene ontology classification of the DEGs from Cd exposed respiratory cells
Ontology
category
Activated
ontology
-log
(adjusted P-value)
Suppressed
ontology
-log
(adjusted P-value)
Biological processesRegulation of lipid biosynthetic process3.7Response to virus3.7
Detoxification of inorganic compound3.7Defense response to virus3.2
Stress response to metal ion3.6Defense response to symbiont3.2
Cellular zinc ion homeostasis3.1Negative regulation of pathway-restricted SMAD protein phosphorylation2.4
Regulation of steroid metabolic process3.1Viral life cycle2.3
Response to Cd ion3.1Negative regulation of cellular response to growth factor stimulus1.7
Zinc ion homeostasis3.0Viral process1.6
Regulation of steroid biosynthetic process3.0Regulation of viral process1.6
Negative regulation of neuron projection development3.0Negative regulation of viral process1.6
Cellular transition metal ion homeostasis2.7Wound healing1.6
Cellular componentsNeuronal cell body4.0--
Cell-cell junction3.2
Apical junction complex3.1
Basal plasma membrane3.0
Basal part of cell3.0
Presynapse2.7
Main axon2.5
Basolateral plasma membrane2.5
Exocytic vesicle2.4
Desmosome2.1
Molecular functionsSterol transporter activity3.4--
Protein binding involved in heterotypiccell-cell adhesion1.8
Alcohol binding1.8
Efflux transmembrane transporter activity1.8
Cell adhesion mediator activity1.8
Phospholipid binding1.8
Cell-cell adhesion mediator activity1.8
Transmembrane receptor protein kinase activity1.6
Amyloid-beta binding1.6
Steroid binding1.6

DEGs, differentially expressed genes; Cd, cadmium; SMAD, suppressor of mothers against decapentaplegic.



In the activated CCs, most gene ontologies are related to cell junctions. ‘Cell-cell junction,’ ‘apical junction,’ and ‘desmosome’ are involved in cell junctions, with ‘desmosome’ being the major intercellular adhesive junctions [28]. ‘Basal plasma membrane’ is also related to cell junctions because the differentiation of the apical plasma membrane from the basal plasma membrane is mediated and controlled by lateral cell-cell adhesion junctions [29]. Cell junctions are linked to cell permeability, and as cell junctions tighten, cell permeability decreases [30]. This can be understood as a protective measure against Cd by decreasing cell permeability.

Among activated MFs, ‘cell adhesion mediator activity’ plays a crucial role in reducing cell permeability as described in the CCs. ‘Sterol transporter activity’ and ‘sterol binding’ are intricately linked to both homeostasis and immune functions [31]. This can be interpreted as a defense against Cd, down-regulating cell permeability and up-regulating immune functions.

After considering the overall GO of Cd on respiratory cells, we were able to discern how cells interact with Cd and manifest toxic effects at the cellular level. In respiratory cells, Cd appears to prompt cells to strengthen intercellular junctions as a defense mechanism against Cd permeation. The activation of Cd metabolism and immune functions aims to protect against Cd toxicity. However, the suppression of defense against carcinogens, homeostasis, cellular regeneration, and cell recovery suggests that these are the key molecular mechanism through which Cd exerts its toxic effects.

Comprehensive evaluation of the respiratory toxicity of Cd through biological network

In order to gain a comprehensive understanding of the toxic mechanisms of Cd inhalation in respiratory organs, we constructed a biological network using Pathway Studio version 12.5.0.2 (Elsevier). The biological network including gene-gene interactions, cell processes, primarily inflammation response and lung cancer shows toxic effects in the respiratory system by Cd inhalation (Fig. 2A). Apart from cancer and inflammation, respiratory diseases encompass ‘pulmonary edema,’ ‘asthma,’ ‘adult respiratory distress syndrome,’ ‘pulmonary fibrosis,’ and ‘nasal polyp.’ To identify central genes in the Cd respiratory toxicity network, each gene in the gene-gene interaction network was assessed based on two parameters: edge degree and betweenness centrality. IL1B, FGF2, ABCA1, and ZEB1 displayed high significance in the network.

Figure 2. Inclusive understanding about cadmium (Cd) exposure in respiratory organs.
(A) Comprehensive molecular network for the differentially expressed genes (DEGs) with cell process and diseases. (B) Condensed network containing hub genes. (C) Potential adverse outcome pathways (AOPs) for cadmium carcinogenicity in bronchial epithelium. KEGG, Kyoto Encyclopedia of Genes and Genomes; MIE, molecular initiating event; KE, key event; AO, adverse outcome.

A central network was constructed using these genes, cell processes, and diseases that exhibit a relationship with these central genes (Fig. 2B). The interactions between the central genes and Cd ion were confirmed on the Pathway Studio database, suggesting that the central genes could serve as potential biomarkers for respiratory diseases caused by Cd inhalation. IL1B is a potent pro-inflammatory cytokine secreted by numerous cell types, which plays a crucial protective role against infection and injury [32]. FGF2 possesses broad mitogenic and angiogenic activities, playing key roles in diverse BPs such as wound healing and tumor growth [33]. Wu et al. [34] demonstrated that ABCA1 mediates the transmembrane transport of free intracellular cholesterol and phospholipids to apolipoprotein, maintaining the normal metabolism of intracellular cholesterol. In addition, ABCA1 serves as the main efflux channel of intracellular cholesterol, indirectly affecting proliferation, metastasis, and invasion of various cancer cells by regulating intracellular cholesterol levels [34]. ZEB1 participates in the transcriptional repression of interleukin-2 [35]. Zhang et al. [36] expressed that ZEB1 is crucial for transformation, promoting tumorigenesis, and its overexpression is associated with cancer malignancy in various cancer cells.

In brief, we constructed a biological network to gain a comprehensive understanding of the adverse effects of Cd (Fig. 2A). Cd poisoning is associated with ‘inflammatory response,’ ‘DNA damage,’ ‘apoptosis,’ and ‘oxidative stress.’ (Fig. 2B) Additionally, numerous respiratory diseases were found to be linked to Cd poisoning. Importantly, the identified central genes could serve as potential biomarkers for respiratory cancer caused by Cd inhalation.

Putative AOP of respiratory organ exposed to Cd

To explore the specific toxic mechanism of Cd in respiratory cells, we constructed a putative AOP based on central genes specific to the respiratory (Fig. 2C). This review makes use of the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway to construct putative AOP. The putative AOP for Cd exposure to the respiratory cell encompasses the MAPK signaling pathway. The putative AOP reveals that the expression of IL1B and FGF2 undergo alterations upon Cd exposure. The binding of IL1B to Interleukin 1 receptor type 1 is considered a putative molecular initiating event (MIE). This putative MIE results in changes in MAP3K7 expression, NF-κB expression, and the activation of the Wnt signaling pathway. These three events are regarded as putative key events (KEs). The altered expression of NF-κB by MAP3K7 causes proliferation, inflammation, and anti-apoptosis, whereas the Wnt signaling pathway results in increased cell growth. The theses generated by NF-κB and the Wnt signaling pathway are considered putative AOs. The other MIE involves FGF2 binding to fibroblast growth factor receptor 1. Following this MIE, the RAS signaling pathway is initiated, leading to SRF and JNK binding to DNA. These three events are considered KEs, with SRF and JNK binding to DNA causing proliferation and differentiation, and JNK binding to DNA inducing apoptosis.

Through this putative AOP, we observed that Cd exposure leads to alterations in the expression levels of IL1B and FGF2, resulting in abnormalities in parts of the MAPK signaling pathway. Specifically, dysregulation in the functions of Wnt signaling, NF-κB, and RAS signaling occurs. These KEs contribute to cancer-related cellular processes in cell growth, differentiation, inflammation, and apoptosis.

In summary, by interpreting the results acquired from the GEO database, we identified DEGs derived from the transcriptome of Cd-exposed respiratory cells. Our interpretation was approached from three perspectives: understanding at the cellular level using GO, comprehensive understanding through biological network, and mechanistic insights through the putative AOP. We identified alterations in cell junctions, homeostasis, and the inflammatory response in respiratory cells due to Cd exposure, leading to potential diseases including inflammatory-related diseases and lung cancer. The putative AOP revealed that Cd induces changes in the expression of IL1B and FGF2, potentially causing AOs, such as cancer-related alterations in cell growth, differentiation, inflammation, and apoptosis.

Toxicity of Cd in the prostate from the perspective of GO

Finding GO were conducted using a gene expression dataset (GSE9951) from the GEO database. The dataset was obtained from an experiment in which normal prostate epithelial cells (NPrEC) were exposed to Cd. To understand an interpretation of the changes in the expression of genes related to Cd toxicity, we identified the ontology of each DEGs. The top 10 gene ontologies (adjusted P-value < 0.05) within the BP, CC, and MF categories were identified in the Cd-exposed prostate cells (Table 2).

Gene ontology classification of the DEGs from Cd exposed prostate cells
Ontology
category
Activated
ontology
-log
(adjusted P-value)
Suppressed
ontology
-log
(adjusted P-value)
Biological processesResponse to endoplasmic reticulum stress4.5Response to oxidative stress1.9
Response to topologically incorrect protein4.5Protein processing1.7
Cellular response to topologically incorrect protein4.0Protein maturation1.7
Response to unfolded protein3.5Regulation of mRNA processing1.7
Endoplasmic reticulum unfolded protein response3.0Regulation of mRNA metabolic process1.6
Cellular response to unfolded protein3.0Protein nitrosylation1.4
Regulation of transcription from RNA polymerase II promoter in response to stress2.5Peptidyl-cysteine S-nitrosylation1.4
Cellular response to hypoxia2.5Negative regulation of JUN kinase activity1.4
Cellular response to decreased oxygen levels2.5--
Regulation of DNA-templated transcription in response to stress2.5
Cellular componentsEndoplasmic reticulum lumen5Peroxisome1.6
Endoplasmic reticulum chaperone complex2.4Microbody1.6
Melanosome2.1Cell-substrate junction1.4
Pigment granule2.1SWI/SNF superfamily-type complex1.4
--Intrinsic component of external side of plasma membrane1.4
ATPase complex1.4
Vacuolar lumen1.4
Focal adhesion1.4
Golgi apparatus subcompartment1.4
Molecular functionsChaperone binding1.7Ubiquitin-like protein ligase binding1.3
Receptor ligand activity1.7Ubiquitin protein ligase binding1.3
Signaling receptor activator activity1.7NAD binding1.3
Misfolded protein binding1.7--

DEGs, differentially expressed genes; Cd, cadmium.



In the activated BPs, endoplasmic reticulum stress has been previously linked to inflammation [37]. Among the suppressed BPs, we detected ‘response to oxidative stress,’ ‘protein maturation,’ and ‘negative regulation of JUN kinase activity.’ The down-regulation of genes associated with oxidative stress suggests genetic damage in the prostate due to Cd-induced oxidative stress [38]. Moulis and Thévenod [39] presented that Cd can directly affect protein maturation by blocking transporter. The JNK signaling pathway related to JUN regulates growth control, transformation, and apoptosis [40-42]. Considering the extensive activation and suppression of BPs, it is evident that Cd suppresses protein structure, induces protein dysfunction and abnormal maturation, and promotes transcription in prostate cells under stress.

The activated CCs were primarily related to cellular secretion. Reactive oxygen species (ROS) can be generated by peroxisomes in response to Cd exposure [43]. Mittal and Roberts [44] found that the SWI/SNF superfamily is a chromatin-remodeling complex with a role in tumor suppression. These activated and suppressed CCs can be understood as prostate cells increasing the secretion of factors, weakening cell-substrate junctions, and suppressing tumor suppressor genes.

The activated MFs, including ‘receptor ligand activity’ and ‘misfolded protein binding,’ indicate abnormal protein binding and function. The suppressed MFs, including ‘ubiquitin protein ligase binding,’ suggest decreased protein degradation [45]. These findings indicate abnormal protein binding and degradation due to Cd.

Through every GO of DEGs from Cd exposed prostate cells, Cd appears to have a significant impact on proteins in prostate cells. It affects protein activities such as function, maturation, binding, and degradation. Furthermore, it increases the likelihood of prostate cancer development by inhibiting the activity of the tumor suppressor SWI/SNF superfamily.

Comprehensive exploration of the mechanisms of Cd toxicity in the prostate through biological network

To understand the toxic effects of Cd in the prostate comprehensively, a biological network was constructed using the Pathway Studio. In the biological network (Fig. 3A), prostate cancer, inflammation, and DNA damage are the main detected toxicity. Each gene in the central network (Fig. 3B) was assessed based on edge degree and betweenness centrality to identify central genes in the network. Heme oxygenase-1 (HMOX1), Ras-related C3 botulinum toxin substrate 1 (RAC1), homolog family member A (RHOA), fibronectin 1 (FN1), DNA damage inducible transcript 3 (DDIT3), and endothelin 1 (EDN1) were selected as central genes of the central network. The interactions between the central genes and Cd were confirmed on the Pathway Studio database, suggesting that the central genes could be potential biomarkers of prostate cancer caused by Cd. It was reported that HMOX1 was overexpressed in androgen-dependent prostate cancer cells [46]. RAC1 was also differentially expressed in Cd-treated prostate cells using cohort data [47] and is related to tumor metastasis [48]. RHOA is associated with cytoskeleton regulation [49] and angiogenesis in prostate cancer [50]. FN1 codes for fibronectin protein, a major component of the extracellular matrix [51], and is down-regulated in the prostate cell line PC-3 cells [52]. DDIT3 is linked to endoplasmic reticulum stress, and its mRNA and protein levels are increased in PC-3 cells [53]. EDN1 is a potent vasoconstrictor [54] and is up-regulated in Cd-exposed NPrEC [55].

Figure 3. Inclusive understanding about cadmium (Cd) occupational exposure in prostate.
(A) Comprehensive molecular network for the differentially expressed genes (DEGs) with cell process and diseases. (B) Condensed network containing hub genes. (C) Potential adverse outcome pathways (AOPs) for Cd carcinogenicity in prostate epithelium. KEGG, Kyoto Encyclopedia of Genes and Genomes; ROS, reactive oxygen species; MIE, molecular initiating event; KE, key event; AO, adverse outcome.

In brief, we presented a comprehensive biological network (Fig. 3A) to elucidate the extensive carcinogenic properties of Cd. Cd toxicity exhibits significant associations with central BPs such as ‘inflammatory response,’ ‘DNA repair,’ ‘cell cycle,’ and ‘oxidative stress.’ Furthermore, biological networks revealed a correlation between Cd poisoning and the manifestation of various diseases in the prostate. The identified potential central genes could serve as potential biomarkers of prostate cancer induced by Cd exposure. The biological networks contribute to a comprehensive understanding of the molecular interactions underlying Cd toxicity.

Putative AOP of prostate exposed to Cd

The putative AOP of Cd exposure in the prostate (Fig. 3C) were constructed based on “pathways in cancer” in the KEGG pathway. The alteration of EDN1 gene expression leads to the generation of ROS after Cd exposure in the prostate. The change of EDN1 expression results in abnormal binding between EDN1 and endothelin receptor type A. These two events are considered MIE. This MIE triggers RAS signaling, followed by the differential expression of RAC1 and RHOA. The RHOA expression change induces JNK signaling. These four events are regarded as KEs. After KEs, JNK signaling regulates the apoptosis [56]. Another MIE is ROS generation. After MIE, KEAP1-NRF2 signaling is activated and HMOX1 is differentially expressed. They could be considered KEs. The change in HMOX1 expression affects apoptosis [57]. Oxidative stress caused by Cd can lead to DNA damage [58], and apoptosis resulting from DNA damage could be influenced by Cd exposure.

Through the putative AOP, we anticipate that Cd exposure in prostate leads to changes in the expression of EDN1, HMOX1, RHOA, and RAC1. These result in abnormalities in parts of the cancer pathway. Specifically, the functions of RAS signaling and KEAP1-NRF2 signaling were dysregulated, leading to the inhibition of apoptosis and the onset of cancer.

In summary, we obtained DEGs from the transcriptome of Cd-exposed prostate cells in GEO database. We approached the interpretation from three perspectives: understanding at the cellular level using GO (Table 2), comprehensive understanding through biological network (Fig. 3A and 3B), and mechanistic insights through putative AOP (Fig. 3C). We identified abnormal protein activities, down-regulated tumor suppressor genes in prostate cells due to Cd exposure. These toxic effects could lead to inflammatory-related diseases and prostate cancer. Through putative AOP, we demonstrate that Cd induces changes in the expression of EDN1, HMOX1, RAC1, and RHOA. Thes central genes potentially cause cancer-related alterations such as apoptosis inhibition.

In this review, we discussed the inhalation route as the most prominent scenario for Cd absorption in the human body through three toxicogenomic approach. These approaches provide a comprehensive understanding of the toxicity of Cd in respiratory organs and prostate, particularly its carcinogenicity. We revealed the cellular responses that occur upon exposure to Cd using GO, in addition to providing a comprehensive overview of the carcinogenic toxicity of Cd through biological network, presenting each potential biomarker for respiratory organs and prostate exposed Cd, and exploring the potential carcinogenic mechanisms of Cd using a putative AOP. This review was prepared using only limited public data, so more genomic data need to be integrated. The potential biological networks, potential biomarkers, and putative AOPs that we have proposed will require experimental validation in further research. Investigating the toxic effects of Cd from various perspectives constitutes a promising approach to understanding the complex mechanisms of Cd-induced cancer and diseases.

This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2023R1A2C1003543).

This work was supported by Korea Environment Industry & Technology Institute (KEITI) through Core Technology Development Project for Environmental Diseases Prevention and Management Program, funded by South Korea’s Ministry of Environment (MOE) (grant number 2022003310012).

  1. Witkowska D, Słowik J, Chilicka K. Heavy Metals and human health: possible exposure pathways and the competition for protein binding sites. Molecules 2021;26:6060.
    Pubmed KoreaMed CrossRef
  2. Godt J, Scheidig F, Grosse-Siestrup C, Esche V, Brandenburg P, Reich A, et al. The toxicity of cadmium and resulting hazards for human health. J Occup Med Toxicol 2006;1:22.
    Pubmed KoreaMed CrossRef
  3. Parida L, Patel TN. Systemic impact of heavy metals and their role in cancer development: a review. Environ Monit Assess 2023;195:766.
    Pubmed CrossRef
  4. Waalkes MP. Cadmium carcinogenesis in review. J Inorg Biochem 2000;79:241-4.
    Pubmed CrossRef
  5. Eriksen KT, Halkjær J, Meliker JR, McElroy JA, Sørensen M, Tjønneland A, et al. Dietary cadmium intake and risk of prostate cancer: a Danish prospective cohort study. BMC Cancer 2015;15:177.
    Pubmed KoreaMed CrossRef
  6. Charles C, Rini DS. Cadmium contamination and the role of bioaccumulator plant as a remediation agent. AIP Conf Proc 2018;2014:020126.
    CrossRef
  7. Genchi G, Sinicropi MS, Lauria G, Carocci A, Catalano A. The effects of cadmium toxicity. Int J Environ Res Public Health 2020;17:3782.
    Pubmed KoreaMed CrossRef
  8. Soltanpour Z, Rasoulzadeh Y, Mohammadian Y. Occupational exposure to metal fumes among Iranian welders: systematic review and simulation-based health risk assessment. Biol Trace Elem Res 2023;201:1090-100.
    Pubmed CrossRef
  9. Lombaert N, Gilles M, Verougstraete V. Cadmium monitoring at the workplace: effectiveness of a combination of air- and biomonitoring. Toxics 2023;11:354.
    Pubmed KoreaMed CrossRef
  10. Tavakoli Pirzaman A, Ebrahimi P, Niknezhad S, Vahidi T, Hosseinzadeh D, Akrami S, et al. Toxic mechanisms of cadmium and exposure as a risk factor for oral and gastrointestinal carcinomas. Hum Exp Toxicol 2023;42:9603271231210262.
    Pubmed CrossRef
  11. Zhang Y, Mi M, Zhu N, Yuan Z, Ding Y, Zhao Y, et al. Global burden of tracheal, bronchus, and lung cancer attributable to occupational carcinogens in 204 countries and territories, from 1990 to 2019: results from the global burden of disease study 2019. Ann Med 2023;55:2206672.
    Pubmed KoreaMed CrossRef
  12. Chandrasekaran B, Dahiya NR, Tyagi A, Kolluru V, Saran U, Baby BV, et al. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis 2020;9:23.
    Pubmed KoreaMed CrossRef
  13. Ledda C, Bracci M, Spadafora A, Motta G, Smecca G, Catelan D, et al. Unmasking the hidden danger: a decade-long systematic review of case-control studies on single occupational risks and prostate cancer. Life (Basel) 2023;13:1820.
    Pubmed KoreaMed CrossRef
  14. Fireman Klein E, Klein I, Ephrat O, Dekel Y, Kessel A, Adir Y. Trajectory of inhaled cadmium ultrafine particles in smokers. BMJ Open Respir Res 2021;8:e001000.
    Pubmed KoreaMed CrossRef
  15. Leal MFC, Catarino RI, Pimenta AM, Souto MRS. The influence of the biometals Cu, Fe, and Zn and the toxic metals Cd and Pb on human health and disease. Trace Elem Electrol 2023;40:1.
    CrossRef
  16. Orosun MM, Nwabachili S, Alshehri RF, Omeje M, Alshdoukhi IF, Okoro HK, et al. Potentially toxic metals in irrigation water, soil, and vegetables and their health risks using Monte Carlo models. Sci Rep 2023;13:21220.
    Pubmed KoreaMed CrossRef
  17. Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol 2016;1418:93-110.
    Pubmed KoreaMed CrossRef
  18. Nudin A, Ellmi A, Petalcorin MIR, Lu ZH, Shafqat N. Comparative proteomic analysis. Reference Module in Life Sciences, 2018.
    CrossRef
  19. Rim KT. Evaluations of carcinogens from comparison of cancer slope factors: meta-analysis and systemic literature reviews. Mol Cell Toxicol 2023;19:635-56.
    CrossRef
  20. Schaefer K, Bansal B, Singhal S, Gill JS, Singhal S. High content predictive models and new alternative methods (NAMs) in the context of adverse outcome pathways (AOPs) to assess arsenic toxicology. In: Flora SJS, ed. Handbook of Arsenic Toxicology. Elsevier, pp 883-98, 2023.
    Pubmed KoreaMed CrossRef
  21. Derynck R. SMAD proteins and mammalian anatomy. Nature 1998;393:737-9.
    Pubmed CrossRef
  22. Attisano L, Lee-Hoeflich ST. The Smads. Genome Biol 2001;2:REVIEWS3010.
    Pubmed KoreaMed CrossRef
  23. Souchelnytskyi S, Rönnstrand L, Heldin CH, ten Dijke P. Phosphorylation of Smad signaling proteins by receptor serine/threonine kinases. Methods Mol Biol 2001;124:107-20.
    Pubmed CrossRef
  24. Guglielmi L, Heliot C, Kumar S, Alexandrov Y, Gori I, Papaleonidopoulou F, et al. Smad4 controls signaling robustness and morphogenesis by differentially contributing to the Nodal and BMP pathways. Nat Commun 2021;12:6374.
    Pubmed KoreaMed CrossRef
  25. Calthorpe RJ, Poulter C, Smyth AR, Sharkey D, Bhatt J, Jenkins G, et al. Complex roles of TGF-β signaling pathways in lung development and bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2023;324:L285-96.
    Pubmed KoreaMed CrossRef
  26. Desai TJ, Cardoso WV. Growth factors in lung development and disease: friends or foe?. Respir Res 2002;3:2.
    Pubmed KoreaMed CrossRef
  27. Ren X, Zhao M, Lash B, Martino MM, Julier Z. Growth factor engineering strategies for regenerative medicine applications. Front Bioeng Biotechnol 2020;7:469.
    Pubmed KoreaMed CrossRef
  28. Huber O. Structure and function of desmosomal proteins and their role in development and disease. Cell Mol Life Sci 2003;60:1872-90.
    Pubmed CrossRef
  29. Giepmans BN, van Ijzendoorn SC. Epithelial cell-cell junctions and plasma membrane domains. Biochim Biophys Acta 2009;1788:820-31.
    Pubmed CrossRef
  30. Chuntharpursat-Bon E, Povstyan OV, Ludlow MJ, Carrier DJ, Debant M, Shi J, et al. PIEZO1 and PECAM1 interact at cell-cell junctions and partner in endothelial force sensing. Commun Biol 2023;6:358.
    Pubmed KoreaMed CrossRef
  31. Britt RD Jr, Porter N, Grayson MH, Gowdy KM, Ballinger M, Wada K, et al. Sterols and immune mechanisms in asthma. J Allergy Clin Immunol 2023;151:47-59.
    Pubmed KoreaMed CrossRef
  32. Lopez-Castejon G, Brough D. Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev 2011;22:189-95.
    Pubmed KoreaMed CrossRef
  33. Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000;7:165-97.
    Pubmed CrossRef
  34. Wu K, Zou L, Lei X, Yang X. Roles of ABCA1 in cancer. Oncol Lett 2022;24:349.
    Pubmed KoreaMed CrossRef
  35. Wang J, Lee S, Teh CE, Bunting K, Ma L, Shannon MF. The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells. Int Immunol 2009;21:227-35.
    Pubmed CrossRef
  36. Zhang Y, Xu L, Li A, Han X. The roles of ZEB1 in tumorigenic progression and epigenetic modifications. Biomed Pharmacother 2019;110:400-8.
    Pubmed CrossRef
  37. Boden G. Insulin resistance and inflammation: links between obesity and cardiovascular disease. In: Watson RR, Dokken BB, eds. Glucose Intake and Utilization in Pre-Diabetes and Diabetes. Elsevier, pp 95-101, 2015.
    CrossRef
  38. Rapisarda V, Miozzi E, Loreto C, Matera S, Fenga C, Avola R, et al. Cadmium exposure and prostate cancer: insights, mechanisms and perspectives. Front Biosci (Landmark Ed) 2018;23:1687-700.
    Pubmed CrossRef
  39. Moulis JM, Thévenod F. New perspectives in cadmium toxicity: an introduction. Biometals 2010;23:763-8.
    Pubmed CrossRef
  40. Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 2003;25:17-24.
    Pubmed CrossRef
  41. Sun W, Liu H, Zhu H, Gao M, Xu S. Eucalyptol antagonized the apoptosis and immune dysfunction of grass carp hepatocytes induced by tetrabromobisphenol A by regulating ROS/ASK1/JNK pathway. Environ Toxicol 2023;38:820-32.
    Pubmed CrossRef
  42. Al Amin M, Emran TB, Khan J, Zehravi M, Sharma I, Patil A, et al. Research progress of indole alkaloids: targeting MAP kinase signaling pathways in cancer treatment. Cancers (Basel) 2023;15:5311.
    Pubmed KoreaMed CrossRef
  43. Sandalio LM, Romero-Puertas MC. Peroxisomes sense and respond to environmental cues by regulating ROS and RNS signalling networks. Ann Bot 2015;116:475-85.
    Pubmed KoreaMed CrossRef
  44. Mittal P, Roberts CWM. The SWI/SNF complex in cancer - biology, biomarkers and therapy. Nat Rev Clin Oncol 2020;17:435-48.
    Pubmed KoreaMed CrossRef
  45. Hou C, Li Y, Wang M, Wu H, Li T. Systematic prediction of degrons and E3 ubiquitin ligase binding via deep learning. BMC Biol 2022;20:162.
    Pubmed KoreaMed CrossRef
  46. Zhang Y, Chen B, Xu N, Xu P, Lin W, Liu C, et al. Exosomes promote the transition of androgen-dependent prostate cancer cells into androgen-independent manner through up-regulating the heme oxygenase-1. Int J Nanomedicine 2021;16:315-27.
    Pubmed KoreaMed CrossRef
  47. Xiang Y, Zhang L, Huang Y, Ling J, Zhuo W. Microarray-based data mining reveals key genes and potential therapeutic drugs for Cadmium-induced prostate cell malignant transformation. Environ Toxicol Pharmacol 2019;68:141-7.
    Pubmed CrossRef
  48. Sun Q, Zhao X, Liu X, Wang Y, Huang J, Jiang B, et al. miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1. Prostate 2014;74:1613-21.
    Pubmed CrossRef
  49. Shimizu A, Mammoto A, Italiano JE Jr, Pravda E, Dudley AC, Ingber DE, et al. ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells. J Biol Chem 2008;283:27230-8.
    Pubmed KoreaMed CrossRef
  50. Chen W, Mao K, Liu Z, Dinh-Xuan AT. The role of the RhoA/Rho kinase pathway in angiogenesis and its potential value in prostate cancer (Review). Oncol Lett 2014;8:1907-11.
    Pubmed KoreaMed CrossRef
  51. Krzyzanowska-Gołab D, Lemańska-Perek A, Katnik-Prastowska I. [Fibronectin as an active component of the extracellular matrix]. Postepy Hig Med Dosw (Online) 2007;61:655-63. Polish.
    Pubmed
  52. Hybel TE, Dietrichs D, Sahana J, Corydon TJ, Nassef MZ, Wehland M, et al. Simulated microgravity influences VEGF, MAPK, and PAM signaling in prostate cancer cells. Int J Mol Sci 2020;21:1263.
    Pubmed KoreaMed CrossRef
  53. Kim KY, Seo YK, Yu SN, Kim SH, Suh PG, Ji JH, et al. Gene expression profiling from a prostate cancer PC-3 cell line treated with salinomycin predicts cell cycle arrest and endoplasmic reticulum stress. J Cancer Sci Ther 2013;5:1.
  54. Tayler H, Miners JS, Güzel Ö, MacLachlan R, Love S. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia. Brain Pathol 2021;31:e12935.
    Pubmed KoreaMed CrossRef
  55. Bakshi S, Zhang X, Godoy-Tundidor S, Cheng RY, Sartor MA, Medvedovic M, et al. Transcriptome analyses in normal prostate epithelial cells exposed to low-dose cadmium: oncogenic and immunomodulations involving the action of tumor necrosis factor. Environ Health Perspect 2008;116:769-76.
    Pubmed KoreaMed CrossRef
  56. Saleem MZ, Alshwmi M, Zhang H, Din SRU, Nisar MA, Khan M, et al. Inhibition of JNK-mediated autophagy promotes proscillaridin A- induced apoptosis via ROS generation, intracellular Ca+2 oscillation and inhibiting STAT3 signaling in breast cancer cells. Front Pharmacol 2020;11:01055.
    Pubmed KoreaMed CrossRef
  57. Rybarczyk A, Majchrzak-Celińska A, Krajka-Kuźniak V. Targeting Nrf2 signaling pathway in cancer prevention and treatment: the role of cannabis compounds. Antioxidants (Basel) 2023;12:2052.
    Pubmed KoreaMed CrossRef
  58. Li Q, Feng Y, Wang R, Liu R, Ba Y, Huang H. Recent insights into autophagy and metals/nanoparticles exposure. Toxicol Res 2023;39:355-72.
    Pubmed CrossRef

Share this article on :

Related articles in JCP

Most KeyWord